Natural History of Atypical Morquio A Disease
Recruiting
- Conditions
- Mucopolysaccharidosis IV A
- Interventions
- Drug: Elosulfase Alfa 1 MG/ML Intravenous Solution [VIMIZIM]
- First Posted Date
- 2017-07-02
- Last Posted Date
- 2024-08-06
- Lead Sponsor
- GOIZET
- Target Recruit Count
- 10
- Registration Number
- NCT03204370
- Locations
- 🇫🇷
Rheumatology department - Bordeaux University Hospital, Bordeaux, Aquitaine, France
© Copyright 2025. All Rights Reserved by MedPath